About: Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk) կլինիկական փորձարկում (hy)
rdfs:label	Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (en) Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (nl)
skos:prefLabel	Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (en) Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (nl)
name	Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (en) Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (nl)
title	wds:Q66038009-5D3F37C9-C3D3-4980-A56F-FCE2AB506BE7
title	A Randomized, Double-Blind, Placebo-controlled, Multi-dose Phase 2 Study to Determine the Efficacy, Safety and Tolerability of AMG 162 in the Treatment of Postmenopausal Women With Low Bone Mineral Density (en)
end time	wds:Q66038009-1C4CF384-C9BD-4F29-99D1-0E8812EE9CD8
end time	2007-04-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66038009-E5C6215F-B0B0-4139-B026-820948848B79
instance of	clinical trial
start time	wds:Q66038009-6B6A07A1-4331-4DCA-8E9A-FCEC8963EF71
start time	2002-05-01 00:00:00Z (xsd:dateTime)
research intervention	wds:Q66038009-A6573BDD-5A61-43FA-8F78-F76A145D582D
research intervention	alendronate sodium trihydrate / colecalciferol
number of participants	wds:Q66038009-98AA4199-795A-4280-93B8-B4DE8FC31B66
number of participants	412 (xsd:decimal)
maximum age	wds:Q66038009-34CB05C3-95CA-41A2-AA8D-32F4745C63C4
maximum age	80 (xsd:decimal)
study type	wds:Q66038009-FFBFB2F1-065C-4F4A-AA42-D67BDBB1826D
study type	interventional study
ClinicalTrials.gov ID	wds:Q66038009-42A94E9B-BC36-4FB4-A90E-353C772211A4
ClinicalTrials.gov ID	NCT00043186
clinical trial phase	wds:Q66038009-98336542-6F68-45EF-98C8-35600CBF1214
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66038009

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software